Clinical Trial Update: Canrenone as Add-on in Patients With Essential Hypertension [Phase 4]

View source ↗

Summary

A Phase 4 trial evaluating canrenone as add-on therapy for essential hypertension has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Essential Hypertension

Drugs mentioned

• Canrenone (canrenone)

Snippet

Sponsor: University of Pavia | Conditions: Essential Hypertension | Phase 4 | Status: COMPLETED